monoclonal-antibodies

Documents about monoclonal-antibodies

• Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety#478485Europe PMC
• Subarachnoid neurocysticercosis in a rural area of the Bolivian Chaco: A population-based survey through the use of a novel urine antigen assay#136441PLOS
• Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo‐Like Kinase 1 Interdomain Linker Affect Mitotic Behavior#176828HAL (France)
• The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities.#240441PubMed
• Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#309484PubMed
• Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS#301207HAL (France)
• Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults#993268ClinicalTrials.gov
• A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults#904364ClinicalTrials.gov
• Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies#851367ClinicalTrials.gov
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2#907959ClinicalTrials.gov
• Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3#121864HAL (France)
• Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.#900060ClinicalTrials.gov
• Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients#893033ClinicalTrials.gov
• Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies#831363ClinicalTrials.gov
• Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection#1033437ClinicalTrials.gov
• EXCIPIENTS FOR ENHANCING MONOCLONAL ANTIBODY STABILITY IN ORAL SOLID DOSAGE FORMS#288533ScholarBank@NUS
• FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#279502ClinicalTrials.gov
• Predicting Agitation Stability of Monoclonal Antibodies during Developability Assessment.#258152NCBI PubMed Central
• Local electrostatics governs tryptophan oxidation and enables rational stability engineering in antibodies.#455653PubMed
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing.#404592PubMed
• The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities.#236390NCBI PubMed Central
• Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies#454050ClinicalTrials.gov
• Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)#826174ClinicalTrials.gov
• Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study#185586IRIS
• Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants#268073ClinicalTrials.gov
• Dupilumab for recalcitrant prurigo nodularis: Case report#335990RCAAP
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing#651931Europe PMC
• Culture-Independent Diagnosis of<i>Chlamydia trachomatis</i>Using Monoclonal Antibodies#383919CiNii
• MicroRNA Profile and Erenumab Treatment#881092ClinicalTrials.gov
• FC-OPTIMIZATION OF DNA-ENCODED MONOCLONAL ANTIBODIES: AN ALTERNATIVE APPROACH TO COMBATING ANTIMICROBIAL RESISTANCE#637519ScholarlyCommons at Penn
• Energy-based generative models for monoclonal antibodies#68268HAL (France)
• Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#308932NCBI PubMed Central
• Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development#370859HAL (France)
• Phase I/II, Open-Label Trial of Three Monoclonal Antibodies#1030316ClinicalTrials.gov
• Rituximab to Treat Neuropathy With Anti-MAG Antibodies#968894ClinicalTrials.gov
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV#886687ClinicalTrials.gov
• Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.#140481NCBI PubMed Central
• Defining mechanisms of protective antibody responses induced by vaccines against blood-stage Plasmodium vivax malaria#211635Ora Oxford University Research
• Exploring the Other Side of Medication: A Patient Interview Study on Anti-PCSK9 Monoclonal Antibodies.#288876NCBI PubMed Central
• Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates#300944HAL (France)
• Infection prophylaxis following anti-CD20 monoclonal antibodies in childhood kidney diseases#416635Springer Nature OA
• In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus#238950HAL (France)
• Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.#174857ClinicalTrials.gov
• Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis#835904ClinicalTrials.gov
• Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV#994276ClinicalTrials.gov
• Advancing SARS-CoV-2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure#342289KOASAS: KAIST Open Access Self-Archiving System
• Characterization of the Migration Profile of 36 Therapeutic Monoclonal Antibodies in Serum Protein Electrophoresis and Immunofixation#374434HAL (France)
• Study of IMC-EB10 in Participant With Leukemia#967858ClinicalTrials.gov
• Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation#1030428ClinicalTrials.gov
• Methyl-specific NMR of therapeutic antibodies: cost-effective isotopic labeling strategies in CHO cells for high-resolution structural characterization#31408HAL (France)